Paul S Rennie Selected Research

Intravenous Injections

1/2016	A Glu-urea-Lys Ligand-conjugated Lipid Nanoparticle/siRNA System Inhibits Androgen Receptor Expression In Vivo.
5/2010	Transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1 for targeting prostate tumors.
3/2010	Bioengineered viral vectors for targeting and killing prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul S Rennie Research Topics

Disease

82	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 05/2002
56	Neoplasms (Cancer) 01/2024 - 06/2004
4	Breast Neoplasms (Breast Cancer) 02/2018 - 01/2010
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017 - 06/2008
3	Adenocarcinoma 12/2018 - 07/2007
3	Carcinogenesis 01/2012 - 07/2007
2	Carcinoma (Carcinomatosis) 10/2017 - 12/2009
2	Disease Progression 03/2013 - 06/2012
2	Neoplasm Metastasis (Metastasis) 03/2012 - 07/2007
1	Brain Neoplasms (Brain Tumor) 11/2018
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Endocrine Gland Neoplasms (Cancer, Endocrine) 10/2017
1	Malaria 01/2017
1	Urologic Neoplasms (Urological Cancer) 06/2016
1	Glioma (Gliomas) 05/2016
1	Prostatic Intraepithelial Neoplasia 05/2016

Drug/Important Bio-Agent (IBA)

55	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 05/2002
33	AndrogensIBA 01/2022 - 05/2002
20	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2003
14	Hormones (Hormone)IBA 11/2018 - 06/2004
13	Transcription Factors (Transcription Factor)IBA 01/2024 - 06/2013
12	LigandsIBA 03/2021 - 12/2002
9	Androgen Antagonists (Antiandrogens)IBA 10/2017 - 05/2007
8	enzalutamideIBA 12/2016 - 02/2013
6	Small Interfering RNA (siRNA)IBA 01/2021 - 11/2006
6	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 05/2003
6	Prostate-Specific Antigen (Semenogelase)IBA 01/2016 - 11/2006
4	LuciferasesIBA 01/2018 - 11/2006
4	Carboxy-LyasesIBA 06/2012 - 01/2007
4	Levodopa (L Dopa)FDA LinkGeneric 06/2012 - 01/2007
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2017 - 12/2014
3	Phosphotransferases (Kinase)IBA 05/2016 - 03/2006
3	AntigensIBA 01/2016 - 03/2007
3	EnzymesIBA 12/2013 - 01/2007
3	Messenger RNA (mRNA)IBA 07/2012 - 03/2012
3	bicalutamide (Casodex)FDA LinkGeneric 06/2012 - 10/2003
3	beta CateninIBA 04/2005 - 05/2002
2	Semaphorins (Semaphorin)IBA 01/2024 - 02/2017
2	ProdrugsIBA 10/2021 - 01/2011
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2010
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 02/2019
2	Activating Transcription Factor 4IBA 01/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2017
2	SteroidsIBA 11/2018 - 01/2016
2	Orphan Nuclear ReceptorsIBA 11/2018 - 12/2014
2	Furylfuramide (AF2)IBA 02/2018 - 02/2015
2	Estrogen ReceptorsIBA 02/2018 - 12/2014
2	Proteoglycans (Proteoglycan)IBA 01/2017 - 04/2005
2	Steroid Synthesis InhibitorsIBA 12/2016 - 07/2015
2	Viral DNAIBA 05/2016 - 05/2010
2	Lipid NanoparticlesIBA 01/2016 - 09/2012
2	Dihydrotestosterone (Androstanolone)IBA 03/2013 - 11/2007
2	Carbidopa (Lodosyn)FDA LinkGeneric 06/2012 - 06/2012
2	Trastuzumab (Herceptin)FDA Link 01/2011 - 03/2010
2	Firefly LuciferasesIBA 01/2011 - 06/2008
2	AntibodiesIBA 01/2011 - 03/2010
2	5' Untranslated Regions (5' UTR)IBA 05/2010 - 03/2010
2	Complementary DNA (cDNA)IBA 12/2009 - 03/2007
2	AutoantibodiesIBA 12/2009 - 03/2007
2	Tetracycline (Achromycin)FDA LinkGeneric 01/2009 - 06/2007
2	Versicans (Versican)IBA 11/2007 - 04/2005
2	MetriboloneIBA 11/2007 - 11/2006
2	probasinIBA 03/2007 - 06/2004
2	TCF Transcription FactorsIBA 04/2005 - 08/2003
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2024
1	Proto-Oncogene Proteins c-etsIBA 01/2020
1	Heterogeneous Nuclear Ribonucleoprotein A1IBA 02/2019
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 02/2019
1	Protein Isoforms (Isoforms)IBA 02/2019
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 02/2019
1	RNA Precursors (Precursor, mRNA)IBA 02/2019
1	Ribonucleases (Ribonuclease)IBA 01/2019
1	MKC8866IBA 01/2019
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 04/2018
1	Caspase 3 (Caspase-3)IBA 04/2018
1	protopanaxadiolIBA 04/2018
1	GinsenosidesIBA 04/2018
1	Therapeutic UsesIBA 01/2018
1	TOPSIBA 01/2018
1	4,4'-dibenzamido-2,2'-stilbenedisulfonic acidIBA 10/2017
1	ChromatinIBA 10/2017
1	chondroitin sulfate proteoglycan 4IBA 01/2017
1	GlycosaminoglycansIBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	SugarsIBA 01/2017
1	Recombinant ProteinsIBA 01/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2017
1	abirateroneIBA 12/2016
1	Eukaryotic Initiation Factor-4EIBA 05/2016
1	SurvivinIBA 05/2016
1	Molecular Chaperones (Chaperone, Molecular)IBA 05/2016
1	Choline KinaseIBA 05/2016
1	Cell-Free Nucleic AcidsIBA 01/2016
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2016

Therapy/Procedure

35	Castration 01/2024 - 11/2006
35	Therapeutics 10/2021 - 05/2003
3	Intravenous Injections 01/2016 - 03/2010
2	Oncolytic Virotherapy 01/2018 - 06/2016
1	Drug Therapy (Chemotherapy) 01/2017
1	Neoadjuvant Therapy 01/2017